Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators
- 21 April 2021
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 191 (7), 1193-1208
- https://doi.org/10.1016/j.ajpath.2021.04.006
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- Federal Ministry of Education and Research Berlin Office
- DZIF
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
- National Eye Institute
This publication has 63 references indexed in Scilit:
- TGF-β1 regulates cell fate during epithelial–mesenchymal transition by upregulating survivinCell Death & Disease, 2013
- Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1–CBFβ interactionProceedings of the National Academy of Sciences of the United States of America, 2012
- TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotypeBlood, 2008
- Furin at the cutting edge: From protein traffic to embryogenesis and diseaseNature Reviews Molecular Cell Biology, 2002
- Human Recombinant Interferon-α2a and Interferon-αA/D Have Different Effects on Bleomycin-Induced Lung InjuryRespiration, 2001
- Effect of Immunomodulators on Bleomycin-Induced Lung InjuryRespiration, 1999
- THE EFFECT OF ENOXAPARIN ON BLEOMYCIN-INDUCED LUNG INJURY IN MICEExperimental Lung Research, 1999
- A Randomized Trial of the Activity and Safety of Ro 24-7429 (Tat Antagonist) versus Nucleoside for Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1995
- Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitro.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.Proceedings of the National Academy of Sciences of the United States of America, 1987